Literature DB >> 2292694

Clinical features and associations of 560 cases of motor neuron disease.

T M Li1, E Alberman, M Swash.   

Abstract

In 560 cases of motor neuron disease, studied retrospectively from their case notes in three teaching centres, the age at onset ranged from 13 to 87 years (mean 56 years), and the mean duration of illness until death was 2.6 years. In the subgroup of the disease presenting with progressive bulbar palsy presenting after age 59 years, there was a previously unrecognised excess of females sufficient to equalize the sex ratio of incidence of the disease in this age group. No potentially causative clinical associations emerged; no relation was noted between occupational exposure to leather products, trauma or surgical procedures and the disease. There was a trend for patients with motor neuron disease to give a history of abstention from alcohol.

Entities:  

Mesh:

Year:  1990        PMID: 2292694      PMCID: PMC488311          DOI: 10.1136/jnnp.53.12.1043

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Neurologic disorders following surgery for peptic ulcer disease.

Authors:  M J Koch; P Hoffman; J A Brody; A H Edgar
Journal:  Arch Neurol       Date:  1975-03

2.  Amyotrophic lateral sclerosis in Finland. I: An epidemiologic study.

Authors:  M Jokelainen
Journal:  Acta Neurol Scand       Date:  1977-09       Impact factor: 3.209

3.  [Myatrophic lateralsclerosis].

Authors:  A Müller-Jensen; W Bernhardt
Journal:  Nervenarzt       Date:  1973-03       Impact factor: 1.214

4.  Motor neurone disease in leather workers.

Authors:  C H Hawkes; A J Fox
Journal:  Lancet       Date:  1981-02-28       Impact factor: 79.321

5.  Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis.

Authors:  I I Kessler; E L Diamond
Journal:  Am J Epidemiol       Date:  1971-07       Impact factor: 4.897

6.  Differential diagnosis of motoneurone disease from other neurological conditions.

Authors:  T M Li; S J Day; E Alberman; M Swash
Journal:  Lancet       Date:  1986-09-27       Impact factor: 79.321

7.  Case-control studies of motor neuron disease: association with mechanical injuries.

Authors:  K Kondo; T Tsubaki
Journal:  Arch Neurol       Date:  1981-04

8.  Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths.

Authors:  J F Kurtzke; G W Beebe
Journal:  Neurology       Date:  1980-05       Impact factor: 9.910

9.  Amyotrophic lateral sclerosis. Clinical features and prognosis.

Authors:  A D Rosen
Journal:  Arch Neurol       Date:  1978-10

10.  Clinical features of amyotrophic amyotrophic lateral sclerosis.

Authors:  P David; M Lo Monaco; G Palieri; C Scoppetta; S Servidei; P Tonali; M L Vaccario
Journal:  Ital J Neurol Sci       Date:  1981-05
View more
  12 in total

Review 1.  Conjugal amyotrophic lateral sclerosis: a report on a couple from Sardinia, Italy.

Authors:  M G Rachele; V Mascia; P Tacconi; N Dessi; F Marrosu; M Giagheddu
Journal:  Ital J Neurol Sci       Date:  1998-04

2.  A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents.

Authors:  L G Gunnarsson; L Bodin; B Söderfeldt; O Axelson
Journal:  Br J Ind Med       Date:  1992-11

3.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

4.  The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

Review 5.  Motor neuron disease.

Authors:  P N Leigh; K Ray-Chaudhuri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

Review 6.  Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics.

Authors:  Ranjeet Prasad Dash; R Jayachandra Babu; Nuggehally R Srinivas
Journal:  Clin Pharmacokinet       Date:  2018-11       Impact factor: 6.447

7.  Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.

Authors:  Michael J Goldacre; Marie Duncan; Myfanwy Griffith; Martin R Turner
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

8.  The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register.

Authors:  A M Chancellor; J M Slattery; H Fraser; R J Swingler; S M Holloway; C P Warlow
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

9.  Genetic epidemiology of motor neuron disease-associated variants in the Scottish population.

Authors:  Holly A Black; Danielle J Leighton; Elaine M Cleary; Elaine Rose; Laura Stephenson; Shuna Colville; David Ross; Jon Warner; Mary Porteous; George H Gorrie; Robert Swingler; David Goldstein; Matthew B Harms; Peter Connick; Suvankar Pal; Timothy J Aitman; Siddharthan Chandran
Journal:  Neurobiol Aging       Date:  2016-12-21       Impact factor: 4.673

Review 10.  Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors:  Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.